sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Announces Investor Webcast for Q2 2026 Financial Review
Jaguar Health, Inc. (NASDAQ: JAGX) will host an investor webcast on August 19, 2026, at 4:30 p.m. Eastern to discuss its Q2 2026 financial results and present corporate updates. This announcement follows the company's plan to file its earnings report for the quarter ended June 30, 2026, on the same day.
The webcast will provide an opportunity for investors to gain insights into Jaguar's financial performance and recent corporate developments. Interested participants can register and access the webcast through the company's investor relations page. A replay will also be available after the event.
Jaguar Health is committed to advancing its portfolio of plant-derived prescription drugs targeting complex gastrointestinal conditions. The company's focus on sustainable development and commercial success in GI and mental health spaces remains a priority.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.